Norwegian biotech firm Hofseth reveals reduced losses on rising revenues

The company has been reporting losses consecutively over the past two years.

Jon Olav Ødegård, CFO Hofseth BioCare — Jon Olav Ødegård, CFO Hofseth BioCarePhoto: Anders Furuset

Demi Korban

Published 15 May 2020, 08:25Updated 15 May 2020, 08:29

biotech Norway Hofseth Biocare Roger Hofseth